Skip to main content

Advertisement

Log in

Apolipoprotein E gene polymorphism in psoriasis

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Polymorphism in the apolipoprotein E gene has been associated with several neurological, cardiological and ophthalmological diseases. Apolipoprotein E is involved in psoriasis by modifying mitogen-activated T lymphocyte proliferation and by assuring protection against some infections. We evaluated the apolipoprotein E gene polymorphism in patients suffering from psoriasis (compared to matched controls) in Thrace, Northern Greece. One hundred and forty patients suffering from psoriasis vulgaris and 155 matched controls were included in this study and genotyped by semi-nested polymerase chain reaction RFLPs; the results were evaluated by conditional logistic regression. In psoriasis vulgaris patients, the e2 allele showed higher frequency (6.1%, P = 0.021) versus matched controls (2.3%). The above data were ascertained particularly enforced in psoriasis vulgaris male patients (P = 0.031) as well as in late onset psoriasis vulgaris (P = 0.029). Implication of apolipoprotein E in the pathogenesis of psoriasis has been indicated. Allele e2 is more frequent in psoriatic patients and its presence is more evident in late onset psoriasis vulgaris.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Angeli V, Liodra J, Rong JX, Satoh K, Shimizu T, Fisher EA, Randolph GJ (2004) Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21:561–574. doi:10.1016/j.immuni.2004.09.003

    Article  PubMed  CAS  Google Scholar 

  2. Bhalerao J, Bowcock A (1998) The genetics of psoriasis: a complex disorder of the skin and immune system. Hum Mol Genet 7(10):1537–1545. doi:10.1093/hmg/7.10.1537

    Article  PubMed  CAS  Google Scholar 

  3. Borroni B, Di Luca M, Padovani A (2007) The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology 68(8):624

    Article  PubMed  Google Scholar 

  4. Bowcock AM, Krueger JG (2005) Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 5:699–711. doi:10.1038/nri1689

    Article  PubMed  CAS  Google Scholar 

  5. Campalani E, Allen MH, Fainhurst D, Young HS, Mendonca CO, Burden AD, Griffiths CEM, Crook MA, Barker JNWN, Smith H (2006) ApoE gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin. Br J Dermatol 154:345–352. doi:10.1111/j.1365-2133.2005.06950.x

    Article  PubMed  CAS  Google Scholar 

  6. Capon F, Helms C, Veal CD, Tillman D, Burden AD, Barker JN, Bowcock AM, Trembath RC (2004) Genetic analysis of PRORS2 markers in UK dataset supports the association between RAPTOR SNPS and familial psoriasis. J Med Genet 41:459–460. doi:10.1136/jmg.2004.018226

    Article  PubMed  CAS  Google Scholar 

  7. Capon F, Di Meglio P, Szaub J, Prescott NJ, Dunster C, Baumber L, Timms K, Gutin A, Abhevic V, Burden AD, Lanchbury J, Barker J, Trembath RC, Nestle FQ (2007) Sequence variants in the genes for the interleukin-23 receptor (IL23 K) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 122:201–206. doi:10.1007/s00439-007-0397-0

    Article  PubMed  CAS  Google Scholar 

  8. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon K, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ, Leong DU, Panko JM, McAllister LB, Hansen CB, Papenfuss J, Prescott SM, White TJ, Leppert MF, Krueger GG, Begovich AB (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80:273–290. doi:10.1086/511051

    Article  PubMed  CAS  Google Scholar 

  9. Cariolou MA, Kokkofitou A, Manoli P, Christou S, Karagrigoriou A, Middleton L (1995) Underexpression of the apolipoprotein E2 and E4 alleles in the Greek Cypriot population of Cyprous. Genet Epidemiol 12(5):489–497. doi:10.1002/gepi.1370120506

    Article  PubMed  CAS  Google Scholar 

  10. Corbo RM, Scacci R (1999) Apolipoprotein E allele distribution in the world. Is apo E4 a thrifty allele? Ann Hum Genet 63(pt 4):301–310. doi:10.1046/j.1469-1809.1999.6340301.x

  11. Das HKJ, McPherson GA, Bruns GAP, Karathanasis SK, Breslow JL (1985) Isolation, characterization and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem 260:6240–6247

    PubMed  CAS  Google Scholar 

  12. Duan H, Li Z, Mazzone T (1995) Tumor Necrosis Factor -a modulates monocyte/macrophage apoE gene expression. J Clin Invest 96:915–922. doi:10.1172/JCI118139

    Article  PubMed  CAS  Google Scholar 

  13. van den Elzen P, Garg S, Leon L, Brigl M, Leadbetter EA, Gumperz JE, Dascher CC, Cheng TY, Sacks FM, Illarionov PA, Besra GS, Kent SC, Moody DB, Brenner MB (2005) Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 437(7060):906–910

    Article  PubMed  CAS  Google Scholar 

  14. Errera FI, Silva ME, Yeh E, Maranduba CM, Folco B, Takahashi W, Pereira AC, Krieger JE, Passos-Bueno MR (2006) Effect of polymorphisms of the MTHFR and apoE genes on susceptibility to diabetes and severity of diabetic retinopathy in Brazilian patients. Braz J Med Biol Res 39(7):883–888. doi:10.1590/S0100-879X2006000700005

    Article  PubMed  CAS  Google Scholar 

  15. Ewbank DC (2004) The APOE Gene and Differences in Life Expectancy in Europe. J Gerontol A Biol Sci Med Sci 59(1):16–20

    PubMed  Google Scholar 

  16. Ferretti G, Alleva R, Taus M, Simonetti O, Cinti B, Offidani AM, Bossi G, Curatola G (1994) Abnormalities of plasma lipoprotein composition and fluidity in psoriasis. Acta Derm Venereol 74(3):171–175

    PubMed  CAS  Google Scholar 

  17. Forte GI, Piccione M, Scola L, Criveflo A, Galfano C, Corsi MM, Chiapelli M, Candore G, Giuffre M, Verna R, Licastro F, Corsello G, Caruso C, Lio D (2007) Apo E genotypic frequencies among Down Syndrome Patients imply early unsuccessful aging for Apo E4 carriers. Rejuvenation Res 10(3):293–299. doi:10.1089/rej.2006.0525

    Article  PubMed  CAS  Google Scholar 

  18. Furumoto H, Nakamura K, Imamura T, Hamamoto Y, Shimizu T, Muto M, Asagami Ch (1997) Association of apo allele e2 with psoriasis vulgaris in Japanese population. Arch Dermatol Res 289:497–500. doi:10.1007/s004030050229

    Google Scholar 

  19. Gerdes LU, Klausen IC, Sihm I, Faergeman O (1992) Apolipoprotein epolymorphism in a Danish population compared to Findings in 45 other study populations around the world. Genet Epidemiol 9(3):155–167. doi:10.1002/gepi.1370090302

    Article  PubMed  CAS  Google Scholar 

  20. Hamamoto Y, Nagai K, Muto M, Furumoto H, Mogami S, Asagami C (1996) Establishment and characterization of a novel human promonocytic line from peripheral blood of a patient with psoriasis. Arch Dermatol Res 288:225–229. doi:10.1007/BF02530089

    Article  PubMed  CAS  Google Scholar 

  21. Henseler T, Christophers E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32:982–986. doi:10.1016/0190-9622(95)91336-X

    Article  PubMed  CAS  Google Scholar 

  22. Hixson JE, Vernier DT (1990) Restriction isotyping of human apoE by gene amplification and cleavage with HhaI. J Lipid Res 31:545–548

    PubMed  CAS  Google Scholar 

  23. Jasinska-Myga B, Opala G, Goetz CG, Tustanowski J, Ochadlo S, Gorzkowska A, Tyrpa J (2007) Apo E gene polymorphism and plasma cholesterol level and Parkinson disease dementia. Arch Neurol 64(2):261–265. doi:10.1001/archneur.64.2.261

    Article  PubMed  Google Scholar 

  24. Kelly ME, Clay MA, Mistry MJ, Hsieh-Li HM, Harmony JAK (1994) Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity. Cell Immunol 159:124–139. doi:10.1006/cimm.1994.1302

    Article  PubMed  CAS  Google Scholar 

  25. Koga T, Duan H, Urabe K, Furue M (2002) In situ localization of CD83-positive dendritic cells in psoriatic lesions. Dermatology 204:100–103. doi:10.1159/000051825

    Article  PubMed  CAS  Google Scholar 

  26. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866–873. doi:10.1038/nature05663

    Article  PubMed  CAS  Google Scholar 

  27. Mallbris L, Granath F, Hamsten A, Stahle M (2006) Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol 54:614–621. doi:10.1016/j.jaad.2005.11.1079

    Article  PubMed  Google Scholar 

  28. Mauri M, Sinforiani E, Bono G, Cittadella R, Quattrone A, Boller F, Nappi G (2006) Interaction between apoE4 and traumatic brain injury in patients with Alzheimer’s disease and Mild Cognitive Impairment. Funct Neurol 21(4):223–228

    PubMed  Google Scholar 

  29. Mehta SG, Watts GD, Adamson JL, Hutton M, Umberger G, Xiong S, Ramdeen S, Lovel MA, Kimonis VE, Smith CD (2007) ApoE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia. Genet Med 9(1):9–13. doi:10.1097/GIM.0b013e31802d830d

    Article  PubMed  CAS  Google Scholar 

  30. Miller SA, Dykes DD, Polesky HF (1998) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215

    Google Scholar 

  31. Miyauchi H (1991) Immunohistochemical study for the localization of apolipoprotein AI, B100 and E in normal and psoriatic skin. Igaku Kenkyu 61(2):79–86

    PubMed  CAS  Google Scholar 

  32. Ng MC, Baum L, So WY, Lam VK, Wang Y, Poon E, Tomlinson B, Cheng S, Lindpainter K, Chan JC (2006) Association of lipoprotein lipase S447x, apoE exon 4 and apo C3-455T-C polymorphism on the susceptibility of diabetic nephropathy. Clin Genet 70(1):20–28. doi:10.1111/j.1399-0004.2006.00628.x

    Article  PubMed  CAS  Google Scholar 

  33. Niu W, Guo X, Su Y, Qiu C (2007) ApoE gene and LDL receptor gene polymorphisms in dyslipidemias associated essential hypertension. J Hum Hypertens 21(4):337–339

    PubMed  CAS  Google Scholar 

  34. Oestreicher JL, Walters IB, Kikuchi T, Gilleaudeau P, Surette J, Schwertschlag U, Dorner AJ, Krueger JG, Trepicchio WL (2001) Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J 1:272–287

    PubMed  CAS  Google Scholar 

  35. Orem A, Cimsit G, Deger O, Orem C, Vanizor B (1999) The significance of autoantibodies against oxidatively modified LDL in patients with psoriasis. Clin Chim Acta 284:81–88. doi:10.1016/S0009-8981(99)00062-5

    Article  PubMed  CAS  Google Scholar 

  36. Panegyres PK, Beilby J, Bulsara M, Toufexis K, Wong C (2006) A study of potential interactive genetic factors in Huntington’s disease. Eur Neurol 55(4):189–192. doi:10.1159/000093867

    Article  PubMed  Google Scholar 

  37. Parmenter BA, Denney DR, Lynch SG, Middleton LS, Harlan LM (2007) Cognitive impairment in patients with multiple sclerosis: association with the apoE gene and promoter polymorphism. Mult Scler 13(1):25–32. doi:10.1177/1352458506070682

    Article  PubMed  CAS  Google Scholar 

  38. Parfenov MG, Nikolaeva TY, Sudomoina MA, Fedorova SA, Guekht AB, Gusev EI, Favorova OO (2007) Polymorphism of apo E and LPL genes and ischaemic stroke in individuals of Yakut ethnicity. J Neurol Sci 255(1–2):42–49

    Article  PubMed  CAS  Google Scholar 

  39. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F (2001) Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 303(1–2):33–39. doi:10.1016/S0009-8981(00)00358-2

    Article  PubMed  CAS  Google Scholar 

  40. Schiele F, De Bacquer D, Vincent-Viry M, Beisiegel U, Ehnholm C, Evans A, Kafatos A, Martins MC, Sans S, Sass C, Visvihis S, De Backer G (2000) Apolipoprotein E serum concentrations and polymorphism in six European countries: the ApoEuropa Project. Atherosclerosis 152:475–488. doi:10.1016/S0021-9150(99)00501-8

    Article  PubMed  CAS  Google Scholar 

  41. Seckin D, Tokgozoglu L, Akkaya S (1994) Are lipoprotein profile and lipoprotein (a) levels altered in men with psoriasis? J Am Acad Dermatol 31(3pt 1):445–449. doi:10.1016/S0190-9622(94)70208-X

    Google Scholar 

  42. Seishima M, Seishima M, Hua S, Abe A, Noma A (1995) ApoE phenotype does not contribute to the pathogenesis of psoriasis. Br J Dermatol 132(1):169–171. doi:10.1111/j.1365-2133.1995.tb08661.x

    Article  PubMed  CAS  Google Scholar 

  43. Seishima M, Seishima M, Mori S, Noma A (1994) Serum lipid and apolipoprotein levels in patient with psoriasis. Br J Dermatol 130(6):738–742. doi:10.1111/j.1365-2133.1994.tb03411.x

    Article  PubMed  CAS  Google Scholar 

  44. Sklavounou E, Economou-Petersen E, Karadima G, Panas M, Avramopoulos D, Varsou A, Vassilopoulos D, Petersen MB (1997) Apolipoprotein E polymorphism in the Greek population. Clin Genet 52(4):216–218

    Article  PubMed  CAS  Google Scholar 

  45. Tziakas DN, Chalikias GK, Antonoglou CO, Veletza S, Tentes JK, Kortsaris AX, Hatseras DI, Kaski JC (2006) ApoE genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease. J Am Coll Cardiol 48(12):2471–2481

    Article  PubMed  CAS  Google Scholar 

  46. Uyanik BS, Ari Z, Onur E, Gunduz K, Tanulku S, Durkan K (2002) Serum lipids and apolipoproteins in patients with psoriasis. Clin Chem Lab Med 40(1):65–68. doi:10.1515/CCLM.2002.013

    Article  PubMed  CAS  Google Scholar 

  47. Vallus G, Dlustrus B, Acsady G, Papp Z, Skopal J, Nagy Z, Prohaszka Z, Romics L, Karadi I, Nagy B (2007) Factor V Leiden and apoE genotypes in severe femoropopliteal atherosclerosis with restenosis. Clin Chim Acta 377(1–2):256–260. doi:10.1016/j.cca.2006.10.004

    Article  PubMed  CAS  Google Scholar 

  48. Waugh WH (2006) Apo E gene and macular degeneration. Ophthalmology 113(10):1888–1889. doi:10.1016/j.ophtha.2006.05.008

    Article  PubMed  Google Scholar 

  49. Weisgraber KH (1994) Apolipoprotein E structure–function relationships. Adv Protein Chem 45:249–302. doi:10.1016/S0065-3233(08)60642-7

    Article  PubMed  CAS  Google Scholar 

  50. Xiao T, Yang C, Xiao Y, Song F (1997) Serum apolipoprotein levels of psoriatic patients with normal serum lipid levels. Chin Med Sci J 12(4):224–228

    PubMed  CAS  Google Scholar 

  51. Xu X, Bittman R, Duportail G, Heissler D, Vilcheze C, London E (2001) Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts). Comparison of cholesterol to plant, fungal and disease-associated sterols and comparison of sphingomyelin, cerebrocides and ceramide. J Biol Chem 276(36):33540–33546. doi:10.1074/jbc.M104776200

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stavroula Vouliana Veletza.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karpouzis, A., Caridha, R., Tripsianis, G. et al. Apolipoprotein E gene polymorphism in psoriasis. Arch Dermatol Res 301, 405–410 (2009). https://doi.org/10.1007/s00403-009-0968-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-009-0968-0

Keywords

Navigation